David R. Rahn & Associates Inc. Abb Vie Inc. Transaction History

David R. Rahn & Associates Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 18, 2018	SELL	$88.91 - $98.84 $1.77 Million - $1.97 Million	-19,907 Closed	0 $0
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $35,912 - $42,492	-400 Reduced 1.97%	19,907 $1.84 Million
Q1 2018 Apr 16, 2018	SELL	$92.01 - $123.21 $1,840 - $2,464	-20 Reduced 0.1%	20,307 $1.92 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $401,318 - $440,079	-4,481 Reduced 18.06%	20,327 $1.97 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $1.73 Million - $2.21 Million	24,808	24,808 $2.2 Million

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of David R. Rahn & Associates Inc., based on Form 13F filings with the SEC.

Stay updated on David R. Rahn & Associates Inc. with notifications on news.